Preview Mode Links will not work in preview mode

May 29, 2018

In the quest for safe, efficacious and profitable therapies, pharma research is changing. There is continued pressure to fill the drug pipeline and, at the same time, globalisation of personalised medicines is complex, expensive and requires a significant time commitment.

With budgets being tight and time scarce,...


May 22, 2018

The use of robots to automate high-volume repetitive tasks has been common practice going back to the early 1970s. Recent advances in robot technology are going to change the breadth of applications suitable for robots and alter how we think about robotic integration.

For researchers in the drug discovery and...


May 15, 2018

Therapeutic antibodies are the fastest growing class of drugs, with continuous increases in the number of innovator and biosimilar drugs in development.

Drug development and clinical trials necessitate the ability to specifically, sensitively and reproducibly measure the concentration and bioavailability of these drugs...


May 8, 2018

Heterocycles are key structural components of many of the anti-cancer drugs available on the market today. Indeed, of the novel molecular anti-cancer agents approved by the FDA between 2010 and 2015, almost two-thirds contained heterocyclic rings within their structures.

In this episode, we look at some of the most...


May 1, 2018

Given their ability to promote long-term survival in a percentage of cancer patients, PD-1/PD-L1 checkpoint inhibitors have fast become foundational cancer therapies. But knowing which patients may respond to these drugs is challenging, in large part because good predictive biomarkers have yet to be identified...